The global market for Diabetic Retinopathy was valued at US$ 8766 million in the year 2024 and is projected to reach a revised size of US$ 13290 million by 2031, growing at a CAGR of 6.2% during the forecast period.

Diabetic Retinopathy Market

Diabetic retinopathy is a disorder of the eye that damages the blood vessels of the retina. The retina is the light-sensitive inner surface of the eye on which images are formed. Long-term diabetes affects the retina as high blood glucose levels can damage the tiny blood vessels in the retina. Diabetic retinopathy is broadly classified into non-proliferative diabetic retinopathy and proliferative retinopathy. Treatment for diabetic retinopathy depends on the stage of the disease and is directed toward slowing down or stopping the progression of the disease.

According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.

Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.

This report aims to provide a comprehensive presentation of the global market for Diabetic Retinopathy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diabetic Retinopathy.

The Diabetic Retinopathy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Diabetic Retinopathy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Diabetic Retinopathy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Diabetic Retinopathy Market Report

Report Metric	Details
Report Name	Diabetic Retinopathy Market
Accounted market size in year	US$ 8766 million
Forecasted market size in 2031	US$ 13290 million
CAGR	6.2%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Laser Surgery Injection of Corticosteroids Anti-VEGF Drugs Vitrectomy
Segment by Application	Hospitals Clinics Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Bayer, Roche, Novartis, TEVA, Alimera Sciences, Regeneron Pharmaceuticals, Boehringer Ingelheim, Kowa Group, Ohr Pharmaceutical, Quark Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Diabetic Retinopathy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Diabetic Retinopathy Market growing?

Ans: The Diabetic Retinopathy Market witnessing a CAGR of 6.2% during the forecast period 2025-2031.

What is the Diabetic Retinopathy Market size in 2031?

Ans: The Diabetic Retinopathy Market size in 2031 will be US$ 13290 million.

Who are the main players in the Diabetic Retinopathy Market report?

Ans: The main players in the Diabetic Retinopathy Market are Bayer, Roche, Novartis, TEVA, Alimera Sciences, Regeneron Pharmaceuticals, Boehringer Ingelheim, Kowa Group, Ohr Pharmaceutical, Quark Pharmaceuticals

What are the Application segmentation covered in the Diabetic Retinopathy Market report?

Ans: The Applications covered in the Diabetic Retinopathy Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the Diabetic Retinopathy Market report?

Ans: The Types covered in the Diabetic Retinopathy Market report are Laser Surgery, Injection of Corticosteroids, Anti-VEGF Drugs, Vitrectomy

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Diabetic Retinopathy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Laser Surgery

1.2.3 Injection of Corticosteroids

1.2.4 Anti-VEGF Drugs

1.2.5 Vitrectomy

1.3 Market by Application

1.3.1 Global Diabetic Retinopathy Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Diabetic Retinopathy Market Perspective (2020-2031)

2.2 Global Diabetic Retinopathy Growth Trends by Region

2.2.1 Global Diabetic Retinopathy Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Diabetic Retinopathy Historic Market Size by Region (2020-2025)

2.2.3 Diabetic Retinopathy Forecasted Market Size by Region (2026-2031)

2.3 Diabetic Retinopathy Market Dynamics

2.3.1 Diabetic Retinopathy Industry Trends

2.3.2 Diabetic Retinopathy Market Drivers

2.3.3 Diabetic Retinopathy Market Challenges

2.3.4 Diabetic Retinopathy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Diabetic Retinopathy Players by Revenue

3.1.1 Global Top Diabetic Retinopathy Players by Revenue (2020-2025)

3.1.2 Global Diabetic Retinopathy Revenue Market Share by Players (2020-2025)

3.2 Global Diabetic Retinopathy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Diabetic Retinopathy Revenue

3.4 Global Diabetic Retinopathy Market Concentration Ratio

3.4.1 Global Diabetic Retinopathy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Diabetic Retinopathy Revenue in 2024

3.5 Global Key Players of Diabetic Retinopathy Head office and Area Served

3.6 Global Key Players of Diabetic Retinopathy, Product and Application

3.7 Global Key Players of Diabetic Retinopathy, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Diabetic Retinopathy Breakdown Data by Type

4.1 Global Diabetic Retinopathy Historic Market Size by Type (2020-2025)

4.2 Global Diabetic Retinopathy Forecasted Market Size by Type (2026-2031)

5 Diabetic Retinopathy Breakdown Data by Application

5.1 Global Diabetic Retinopathy Historic Market Size by Application (2020-2025)

5.2 Global Diabetic Retinopathy Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Diabetic Retinopathy Market Size (2020-2031)

6.2 North America Diabetic Retinopathy Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Diabetic Retinopathy Market Size by Country (2020-2025)

6.4 North America Diabetic Retinopathy Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Diabetic Retinopathy Market Size (2020-2031)

7.2 Europe Diabetic Retinopathy Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Diabetic Retinopathy Market Size by Country (2020-2025)

7.4 Europe Diabetic Retinopathy Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Diabetic Retinopathy Market Size (2020-2031)

8.2 Asia-Pacific Diabetic Retinopathy Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Diabetic Retinopathy Market Size by Region (2020-2025)

8.4 Asia-Pacific Diabetic Retinopathy Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Diabetic Retinopathy Market Size (2020-2031)

9.2 Latin America Diabetic Retinopathy Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Diabetic Retinopathy Market Size by Country (2020-2025)

9.4 Latin America Diabetic Retinopathy Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Diabetic Retinopathy Market Size (2020-2031)

10.2 Middle East & Africa Diabetic Retinopathy Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Diabetic Retinopathy Market Size by Country (2020-2025)

10.4 Middle East & Africa Diabetic Retinopathy Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Bayer

11.1.1 Bayer Company Details

11.1.2 Bayer Business Overview

11.1.3 Bayer Diabetic Retinopathy Introduction

11.1.4 Bayer Revenue in Diabetic Retinopathy Business (2020-2025)

11.1.5 Bayer Recent Development

11.2 Roche

11.2.1 Roche Company Details

11.2.2 Roche Business Overview

11.2.3 Roche Diabetic Retinopathy Introduction

11.2.4 Roche Revenue in Diabetic Retinopathy Business (2020-2025)

11.2.5 Roche Recent Development

11.3 Novartis

11.3.1 Novartis Company Details

11.3.2 Novartis Business Overview

11.3.3 Novartis Diabetic Retinopathy Introduction

11.3.4 Novartis Revenue in Diabetic Retinopathy Business (2020-2025)

11.3.5 Novartis Recent Development

11.4 TEVA

11.4.1 TEVA Company Details

11.4.2 TEVA Business Overview

11.4.3 TEVA Diabetic Retinopathy Introduction

11.4.4 TEVA Revenue in Diabetic Retinopathy Business (2020-2025)

11.4.5 TEVA Recent Development

11.5 Alimera Sciences

11.5.1 Alimera Sciences Company Details

11.5.2 Alimera Sciences Business Overview

11.5.3 Alimera Sciences Diabetic Retinopathy Introduction

11.5.4 Alimera Sciences Revenue in Diabetic Retinopathy Business (2020-2025)

11.5.5 Alimera Sciences Recent Development

11.6 Regeneron Pharmaceuticals

11.6.1 Regeneron Pharmaceuticals Company Details

11.6.2 Regeneron Pharmaceuticals Business Overview

11.6.3 Regeneron Pharmaceuticals Diabetic Retinopathy Introduction

11.6.4 Regeneron Pharmaceuticals Revenue in Diabetic Retinopathy Business (2020-2025)

11.6.5 Regeneron Pharmaceuticals Recent Development

11.7 Boehringer Ingelheim

11.7.1 Boehringer Ingelheim Company Details

11.7.2 Boehringer Ingelheim Business Overview

11.7.3 Boehringer Ingelheim Diabetic Retinopathy Introduction

11.7.4 Boehringer Ingelheim Revenue in Diabetic Retinopathy Business (2020-2025)

11.7.5 Boehringer Ingelheim Recent Development

11.8 Kowa Group

11.8.1 Kowa Group Company Details

11.8.2 Kowa Group Business Overview

11.8.3 Kowa Group Diabetic Retinopathy Introduction

11.8.4 Kowa Group Revenue in Diabetic Retinopathy Business (2020-2025)

11.8.5 Kowa Group Recent Development

11.9 Ohr Pharmaceutical

11.9.1 Ohr Pharmaceutical Company Details

11.9.2 Ohr Pharmaceutical Business Overview

11.9.3 Ohr Pharmaceutical Diabetic Retinopathy Introduction

11.9.4 Ohr Pharmaceutical Revenue in Diabetic Retinopathy Business (2020-2025)

11.9.5 Ohr Pharmaceutical Recent Development

11.10 Quark Pharmaceuticals

11.10.1 Quark Pharmaceuticals Company Details

11.10.2 Quark Pharmaceuticals Business Overview

11.10.3 Quark Pharmaceuticals Diabetic Retinopathy Introduction

11.10.4 Quark Pharmaceuticals Revenue in Diabetic Retinopathy Business (2020-2025)

11.10.5 Quark Pharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Regeneron Pharmaceuticals

Boehringer Ingelheim

Kowa Group

Ohr Pharmaceutical

Quark Pharmaceuticals

List of Tables

Table 1. Global Diabetic Retinopathy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Laser Surgery

Table 3. Key Players of Injection of Corticosteroids

Table 4. Key Players of Anti-VEGF Drugs

Table 5. Key Players of Vitrectomy

Table 6. Global Diabetic Retinopathy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Diabetic Retinopathy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Diabetic Retinopathy Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Diabetic Retinopathy Market Share by Region (2020-2025)

Table 10. Global Diabetic Retinopathy Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Diabetic Retinopathy Market Share by Region (2026-2031)

Table 12. Diabetic Retinopathy Market Trends

Table 13. Diabetic Retinopathy Market Drivers

Table 14. Diabetic Retinopathy Market Challenges

Table 15. Diabetic Retinopathy Market Restraints

Table 16. Global Diabetic Retinopathy Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Diabetic Retinopathy Market Share by Players (2020-2025)

Table 18. Global Top Diabetic Retinopathy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetic Retinopathy as of 2024)

Table 19. Ranking of Global Top Diabetic Retinopathy Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Diabetic Retinopathy Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Diabetic Retinopathy, Headquarters and Area Served

Table 22. Global Key Players of Diabetic Retinopathy, Product and Application

Table 23. Global Key Players of Diabetic Retinopathy, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Diabetic Retinopathy Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Diabetic Retinopathy Revenue Market Share by Type (2020-2025)

Table 27. Global Diabetic Retinopathy Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Diabetic Retinopathy Revenue Market Share by Type (2026-2031)

Table 29. Global Diabetic Retinopathy Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Diabetic Retinopathy Revenue Market Share by Application (2020-2025)

Table 31. Global Diabetic Retinopathy Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Diabetic Retinopathy Revenue Market Share by Application (2026-2031)

Table 33. North America Diabetic Retinopathy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Diabetic Retinopathy Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Diabetic Retinopathy Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Diabetic Retinopathy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Diabetic Retinopathy Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Diabetic Retinopathy Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Diabetic Retinopathy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Diabetic Retinopathy Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Diabetic Retinopathy Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Diabetic Retinopathy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Diabetic Retinopathy Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Diabetic Retinopathy Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Diabetic Retinopathy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Diabetic Retinopathy Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Diabetic Retinopathy Market Size by Country (2026-2031) & (US$ Million)

Table 48. Bayer Company Details

Table 49. Bayer Business Overview

Table 50. Bayer Diabetic Retinopathy Product

Table 51. Bayer Revenue in Diabetic Retinopathy Business (2020-2025) & (US$ Million)

Table 52. Bayer Recent Development

Table 53. Roche Company Details

Table 54. Roche Business Overview

Table 55. Roche Diabetic Retinopathy Product

Table 56. Roche Revenue in Diabetic Retinopathy Business (2020-2025) & (US$ Million)

Table 57. Roche Recent Development

Table 58. Novartis Company Details

Table 59. Novartis Business Overview

Table 60. Novartis Diabetic Retinopathy Product

Table 61. Novartis Revenue in Diabetic Retinopathy Business (2020-2025) & (US$ Million)

Table 62. Novartis Recent Development

Table 63. TEVA Company Details

Table 64. TEVA Business Overview

Table 65. TEVA Diabetic Retinopathy Product

Table 66. TEVA Revenue in Diabetic Retinopathy Business (2020-2025) & (US$ Million)

Table 67. TEVA Recent Development

Table 68. Alimera Sciences Company Details

Table 69. Alimera Sciences Business Overview

Table 70. Alimera Sciences Diabetic Retinopathy Product

Table 71. Alimera Sciences Revenue in Diabetic Retinopathy Business (2020-2025) & (US$ Million)

Table 72. Alimera Sciences Recent Development

Table 73. Regeneron Pharmaceuticals Company Details

Table 74. Regeneron Pharmaceuticals Business Overview

Table 75. Regeneron Pharmaceuticals Diabetic Retinopathy Product

Table 76. Regeneron Pharmaceuticals Revenue in Diabetic Retinopathy Business (2020-2025) & (US$ Million)

Table 77. Regeneron Pharmaceuticals Recent Development

Table 78. Boehringer Ingelheim Company Details

Table 79. Boehringer Ingelheim Business Overview

Table 80. Boehringer Ingelheim Diabetic Retinopathy Product

Table 81. Boehringer Ingelheim Revenue in Diabetic Retinopathy Business (2020-2025) & (US$ Million)

Table 82. Boehringer Ingelheim Recent Development

Table 83. Kowa Group Company Details

Table 84. Kowa Group Business Overview

Table 85. Kowa Group Diabetic Retinopathy Product

Table 86. Kowa Group Revenue in Diabetic Retinopathy Business (2020-2025) & (US$ Million)

Table 87. Kowa Group Recent Development

Table 88. Ohr Pharmaceutical Company Details

Table 89. Ohr Pharmaceutical Business Overview

Table 90. Ohr Pharmaceutical Diabetic Retinopathy Product

Table 91. Ohr Pharmaceutical Revenue in Diabetic Retinopathy Business (2020-2025) & (US$ Million)

Table 92. Ohr Pharmaceutical Recent Development

Table 93. Quark Pharmaceuticals Company Details

Table 94. Quark Pharmaceuticals Business Overview

Table 95. Quark Pharmaceuticals Diabetic Retinopathy Product

Table 96. Quark Pharmaceuticals Revenue in Diabetic Retinopathy Business (2020-2025) & (US$ Million)

Table 97. Quark Pharmaceuticals Recent Development

Table 98. Research Programs/Design for This Report

Table 99. Key Data Information from Secondary Sources

Table 100. Key Data Information from Primary Sources

Table 101. Authors List of This Report

List of Figures

Figure 1. Diabetic Retinopathy Picture

Figure 2. Global Diabetic Retinopathy Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Diabetic Retinopathy Market Share by Type: 2024 VS 2031

Figure 4. Laser Surgery Features

Figure 5. Injection of Corticosteroids Features

Figure 6. Anti-VEGF Drugs Features

Figure 7. Vitrectomy Features

Figure 8. Global Diabetic Retinopathy Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Diabetic Retinopathy Market Share by Application: 2024 VS 2031

Figure 10. Hospitals Case Studies

Figure 11. Clinics Case Studies

Figure 12. Others Case Studies

Figure 13. Diabetic Retinopathy Report Years Considered

Figure 14. Global Diabetic Retinopathy Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Diabetic Retinopathy Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Diabetic Retinopathy Market Share by Region: 2024 VS 2031

Figure 17. Global Diabetic Retinopathy Market Share by Players in 2024

Figure 18. Global Top Diabetic Retinopathy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetic Retinopathy as of 2024)

Figure 19. The Top 10 and 5 Players Market Share by Diabetic Retinopathy Revenue in 2024

Figure 20. North America Diabetic Retinopathy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Diabetic Retinopathy Market Share by Country (2020-2031)

Figure 22. United States Diabetic Retinopathy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Diabetic Retinopathy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Diabetic Retinopathy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Diabetic Retinopathy Market Share by Country (2020-2031)

Figure 26. Germany Diabetic Retinopathy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Diabetic Retinopathy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Diabetic Retinopathy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Diabetic Retinopathy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Diabetic Retinopathy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries Diabetic Retinopathy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Diabetic Retinopathy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Diabetic Retinopathy Market Share by Region (2020-2031)

Figure 34. China Diabetic Retinopathy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Diabetic Retinopathy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Diabetic Retinopathy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Diabetic Retinopathy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Diabetic Retinopathy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia Diabetic Retinopathy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Diabetic Retinopathy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Diabetic Retinopathy Market Share by Country (2020-2031)

Figure 42. Mexico Diabetic Retinopathy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Diabetic Retinopathy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Diabetic Retinopathy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Diabetic Retinopathy Market Share by Country (2020-2031)

Figure 46. Turkey Diabetic Retinopathy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Diabetic Retinopathy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Diabetic Retinopathy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Bayer Revenue Growth Rate in Diabetic Retinopathy Business (2020-2025)

Figure 50. Roche Revenue Growth Rate in Diabetic Retinopathy Business (2020-2025)

Figure 51. Novartis Revenue Growth Rate in Diabetic Retinopathy Business (2020-2025)

Figure 52. TEVA Revenue Growth Rate in Diabetic Retinopathy Business (2020-2025)

Figure 53. Alimera Sciences Revenue Growth Rate in Diabetic Retinopathy Business (2020-2025)

Figure 54. Regeneron Pharmaceuticals Revenue Growth Rate in Diabetic Retinopathy Business (2020-2025)

Figure 55. Boehringer Ingelheim Revenue Growth Rate in Diabetic Retinopathy Business (2020-2025)

Figure 56. Kowa Group Revenue Growth Rate in Diabetic Retinopathy Business (2020-2025)

Figure 57. Ohr Pharmaceutical Revenue Growth Rate in Diabetic Retinopathy Business (2020-2025)

Figure 58. Quark Pharmaceuticals Revenue Growth Rate in Diabetic Retinopathy Business (2020-2025)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions